MCS presents a new video for patients undergoing joint replacement surgery. Follow MCS on LinkedIn for the most recent company news and updates!
"In View" with Larry King showcasing ActiveCare® therapy. ActiveCare® - alternative to anticoagulants for Deep Vein Thrombosis prevention during or after Total Joint Replacement (TJR), Total Knee Replacement (TKR) or Total Hip Replacement (THR) Surgery. For more information please visit activecare.mcsmed.com Larry King showcases ActiveCare Therapy on his “In View” show.
According to Adi Dagan, MCS’s CEO: “The use of the company’s device by America’s number one orthopedic hospital, HSS, is the jewel in the crown that has been added to the leading medical centers already using ActiveCare®+S.F.T.” HSS – America’s Number One Orthopedic Center Selects MCS
MCS Expands into South Korea MCS Wins another Minnesota Medical Center in May
Approximately 2,000 relevant medical procedures are performed annually at these medical centers, and MCS expects its penetration rate to reach about 20% in the first year. MCS Continues to Expand its Reach in the US
MCS is attending the AAOS 2010 Annual Meeting, March 9-13, New Orleans, LA. Booth #437 MCS appoints former VP at Sanofi Aventis as the President of its US subsidiary Landmark Head-to-Head S.A.F.E. Study Comparing ActiveCare®+S.F.T. to Lovenox Published in Journal of Bone & Joint Surgery
MCS is attending the AAOS 2011 Annual Meeting, Feb. 15-19, in San Diego, CA. Booth #5745